Results 81 to 90 of about 3,867 (204)

Heroin-piracetam mixture: suggested mechanisms of action and risks of misinterpretation for drug users [PDF]

, 2017
Piracetam is a positive allosteric modulator of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor that has been frequently used in the treatment of cognitive disorders.
Francesco Lombardo, Pasquale Vitale, Giuseppe Vallone, CAPPELLETTI, SIMONE, Simone Cappelletti, Vitale, Pasquale, Lombardo, Francesco, Costantino Ciallella, CIALLELLA, Costantino, Vallone, Giuseppe   +9 more
core   +1 more source

Extended Delirium Treated as Psychosis

Annals of Indian Psychiatry
Delirium is a commonly seen neuropsychiatric disorder that may extend over time, lasting for more than 60 days, thus increasing the risk of cognitive and behavioral outcomes in patients.
Neena Sawant, Anuradha D. Rathod, Swara Kulkarni, Karishma Rupani   +3 more
doaj   +1 more source

Inhibitory effect of piracetam on platelet-rich thrombus formation in an animal model

, 1998
Intravenous administration of piracetam to hamsters reduced the formation of a platelet-rich venous thrombus induced by a standardised crush injury, in a dose-dependent fashion with an IC50 of 68 +/- 8 mg/kg.
Vermylen, Jozef, H. Deckmyn, Stockmans, Filip, Å. Nyström, J. M. Stassen, W. Deberdt, Deckmyn, Hans, Deberdt, W., E. Nyström, Nyström, A., Nyström, E., J. Vermylen, F. Stockmans, Stassen, J.M.   +13 more
core   +1 more source

The effects of piracetam on cognitive performance in a mouse model of Down\u27s syndrome.

, 2002
Piracetam is a nootropic agent that has been shown to improve cognitive performance in a number of animal model systems. Piracetam is reported to be used widely as a means of improving cognitive function in children with Down\u27s syndrome (DS).
Capone, G T, Reeves, R H, Knipp, S, Gearhart, J D, Moran, T H, Davisson, M T   +5 more
core   +1 more source

Physiological disposition of oral piracetam in Sprague-Dawley rats

, 1984
The distribution and fate of piracetam (2-oxo-1-pyrrolidine acetamide, Nootropil), the prototype ‘nootropic drug’, was examined in rats given 100–1000 mg kg−1 by gavage, with or without [3H]piracetam as a tracer.
Maria T Tacconi, Richard J Wurtman
core   +1 more source

HAEE tetrapeptide as a promising neuroprotector: comparison with Piracetam in an experimental model of Alzheimer's disease

Research Results in Pharmacology
Introduction: During the experiment, the effectiveness of tetrapeptide HAEE and the comparison drug Piracetam in correcting neurodegenerative disorders in Alzheimer's disease was investigated in a model of transgenic mice.
Evgenii A. Patrakhanov, Elеna V. Kuzubova, Nikita S. Zhunusov, Alexandra I. Radchenko, Vladislav Y. Kurdyukov, Anastasia R. Denisova, Alina A. Avramenko, Mikhail V. Pokrovskii   +7 more
doaj   +1 more source

The Effects of Nootropic Drugs on Striatal 5-HT2A-Receptors in Outbred Mice with Different Efficacy of Exploratory Behavior

Фармакокинетика и Фармакодинамика, 2019
Resume. The effect of subchronic administration of nootropic drugs of different structures (piracetam 200 mg/kg/day, pantocalcin 200 mg/kg/day, semax 0.6 mg/ kg/day, nooglutil 50 mg/kg/day) to mice of the outbred line 1CR on spontaneous research activity
Yu. Yu. Firstova, E. V. Vasileva, G. I. Kovalev   +2 more
doaj   +1 more source

The effects of piracetam on morphine-induced amnesia and analgesia: The possible contribution of central opiatergic mechanisms on the antiamnestic effect of piracetam

, 1998
The involvement of optatergic mechanisms on the antiamnestic effects of piracetam was investigated in mice. First, the effects of piracetam and naloxone on the amnesia induced by scopolamine, electroconvulsive shock and morphine were evaluated by using ...
Inan S.Y., Aksu F., Baysal F., Gultekin I.   +3 more
core   +1 more source

Solution-Mediated Polymorphic Transformation: Form II to Form III Piracetam in Organic Solvents

, 2014
NoThe solution-mediated polymorphic transformation from Form II to Form III 2-oxo-1-pyrrolidine acetamide (piracetam) was investigated in seven organic solvents over the temperature range of 5–50 °C.
Rasmuson, Å.C., Maher, A., Hodnett, B.K., Åke C. Rasmuson, Benjamin K. Hodnett, Croker, D.M., Croker, Denise M., Colin C. Seaton, Anthony Maher, Hodnett, Benjamin K., Denise M. Croker, Rasmuson, Åke C.,, Seaton, Colin C., Maher, Anthony   +13 more
core   +1 more source